Literature DB >> 576161

Hypotensive sequelae of diazoxide and hydralazine therapy.

W L Henrich, R Cronin, P D Miller, R J Anderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 576161

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

Review 1.  Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy.

Authors:  P M Kyle; C W Redman
Journal:  Drug Saf       Date:  1992 May-Jun       Impact factor: 5.606

Review 2.  Hypertensive emergencies and urgencies: definition, recognition, and management.

Authors:  J B Reuler; G J Magarian
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

3.  Antihypertensive effect of diazoxide given intravenously in small repeated doses.

Authors:  A McNair; F Andreasen; P E Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  Pharmacokinetics and response to diazoxide in renal failure.

Authors:  R M Pearson
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

5.  Comparison of effects on cerebral blood flow of rapid reduction in systemic arterial pressure by diazoxide and labetalol in hypertensive patients: preliminary findings.

Authors:  R M Pearson; D N Griffith; M Woollard; I M James; C W Havard
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  Decrease of some metabolic and physiologic effects of diazoxide by propranolol in rat.

Authors:  S R Johansson; R G Andersson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-04       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.